These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 32364441)

  • 1. Don't judge too RAShly: the multifaceted role of the renin-angiotensin system and its therapeutic potential in COVID-19.
    Walther T; Kuebler WM
    Am J Physiol Lung Cell Mol Physiol; 2020 May; 318(5):L1023-L1024. PubMed ID: 32364441
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to Letter to the Editor: "Don't judge too RAShly: the multifaceted role of the renin-angiotensin system and its therapeutic potential in COVID-19".
    Abassi ZA; Skorecki K; Heyman SN; Kinaneh S; Armaly Z
    Am J Physiol Lung Cell Mol Physiol; 2020 May; 318(5):L1029-L1030. PubMed ID: 32364440
    [No Abstract]   [Full Text] [Related]  

  • 3. The Renin-Angiotensin system and SARS-CoV-2 infection: A role for the ACE2 receptor?
    Sever P; Johnston SL
    J Renin Angiotensin Aldosterone Syst; 2020; 21(2):1470320320926911. PubMed ID: 32403977
    [No Abstract]   [Full Text] [Related]  

  • 4. Response to recent commentaries regarding the involvement of angiotensin-converting enzyme 2 (ACE2) and renin-angiotensin system blockers in SARS-CoV-2 infections.
    Speth RC
    Drug Dev Res; 2020 Sep; 81(6):643-646. PubMed ID: 32304146
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID-19, Renin-Angiotensin System, and Hematopoiesis.
    Çiftçiler R; Haznedaroğlu İC
    Turk J Haematol; 2020 Aug; 37(3):207-208. PubMed ID: 32394689
    [No Abstract]   [Full Text] [Related]  

  • 6. What Kind of Evidence Is Needed to Dictate Practice Regarding Inhibitors of the Renin-Angiotensin System in COVID-19?
    Elijovich F; Laffer CL
    Hypertension; 2020 Sep; 76(3):665-669. PubMed ID: 32783759
    [No Abstract]   [Full Text] [Related]  

  • 7. Renin-Angiotensin-Aldosterone System Inhibitors and Outcome in Patients With SARS-CoV-2 Pneumonia: A Case Series Study.
    Conversano A; Melillo F; Napolano A; Fominskiy E; Spessot M; Ciceri F; Agricola E
    Hypertension; 2020 Aug; 76(2):e10-e12. PubMed ID: 32383626
    [No Abstract]   [Full Text] [Related]  

  • 8. Inquiring Into Benefits of Independent Activation of Nonclassical Renin-angiotensin System in the Clinical Prognosis and Reduction of COVID-19 Mortality.
    Álvarez-Aragón LM; Cuesta-Muñoz AL; Álvarez-López I
    Clin Infect Dis; 2020 Jul; 71(15):894-895. PubMed ID: 32266375
    [No Abstract]   [Full Text] [Related]  

  • 9. Renin-Angiotensin-Aldosterone System Inhibitors Impact on COVID-19 Mortality: What's Next for ACE2?
    Patel AB; Verma A
    Clin Infect Dis; 2020 Nov; 71(16):2129-2131. PubMed ID: 32442259
    [No Abstract]   [Full Text] [Related]  

  • 10. Comment on "ACE inhibitors and COVID-19: We don't know yet".
    Ilcol TB; Cure E; Cumhur Cure M
    J Card Surg; 2020 Jun; 35(6):1387. PubMed ID: 32531125
    [No Abstract]   [Full Text] [Related]  

  • 11. Good things come in threes (and sometimes fours): Update on renin-angiotensin-aldosterone system inhibitors and COVID-19.
    Quinn KL; Fralick M; Zipursky JS; Stall NM
    CMAJ; 2020 Jun; 192(22):E611. PubMed ID: 32575050
    [No Abstract]   [Full Text] [Related]  

  • 12. Is there enough evidence to discontinue the renin-angiotensin system inhibitors in patients with COVID-19?
    Bobkova I; Kamyshova E; Rudenko T; Stavrovskaya E; Moiseev S
    Med Hypotheses; 2020 Oct; 143():109888. PubMed ID: 32480248
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hypertension, RAAS blockade and risk in COVID-19 patients].
    Spaak J; Kahan T
    Lakartidningen; 2020 Jun; 117():. PubMed ID: 32594472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter in response to the article: Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers (Singh et al.).
    Mahajan K; Gaur N
    Diabetes Metab Syndr; 2020; 14(5):723-724. PubMed ID: 32473902
    [No Abstract]   [Full Text] [Related]  

  • 15. SARS-CoV-2 & Covid-19: Key-Roles of the 'Renin-Angiotensin' System / Vitamin D Impacting Drug and Vaccine Developments.
    Cao Z; Wu Y; Faucon E; Sabatier JM
    Infect Disord Drug Targets; 2020; 20(3):348-349. PubMed ID: 32370727
    [No Abstract]   [Full Text] [Related]  

  • 16. RAAS Inhibitors and Risk of Covid-19.
    Sriram K; Loomba R; Insel PA
    N Engl J Med; 2020 Nov; 383(20):1991-1992. PubMed ID: 33108103
    [No Abstract]   [Full Text] [Related]  

  • 17. RAAS Inhibitors and Risk of Covid-19.
    Angeli F; Verdecchia P; Reboldi G
    N Engl J Med; 2020 Nov; 383(20):1990-1991. PubMed ID: 33108102
    [No Abstract]   [Full Text] [Related]  

  • 18. [Scientific statement on using of renin angiotensin system blockers in patients with cardiovascular disease and COVID-19].
    ;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):565-566. PubMed ID: 32842268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renin-angiotensin system inhibitors in the COVID-19 pandemic: consequences of antihypertensive drugs.
    Ruilope LM; Tamargo J; Ruiz-Hurtado G
    Eur Heart J; 2020 Jun; 41(22):2067-2069. PubMed ID: 32498078
    [No Abstract]   [Full Text] [Related]  

  • 20. [ACE2 and coronavirus - a question of balance and dynamics?].
    Lundström A; Sandén P
    Lakartidningen; 2020 Apr; 117():. PubMed ID: 32314329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.